Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...

Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

Here is our list of the 11 best cancer stocks to buy right now.

The average dividend yield in the S&P 500 Index remains low at around 1.3%. As a result, many stocks have lower dividend ...

Personalized and targeted cancer therapies are showing unprecedented promise, with novel approaches potentially ...

Bristol-Myers Squibb has been navigating some choppy waters but seems poised for a turnaround. Recently, shares have ticked ...

Bristol-Myers Squibb Company is pushing the boundaries with its latest clinical study on Deucravacitinib. The drug targets moderate to severe systemic lupus erythematosus (SLE). Employing a ...